LumiraDx Revenue and Competitors

London, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • LumiraDx's estimated annual revenue is currently $347.8M per year.(i)
  • LumiraDx's estimated revenue per employee is $378,000

Employee Data

  • LumiraDx has 920 Employees.(i)
  • LumiraDx grew their employee count by -29% last year.

LumiraDx's People

NameTitleEmail/Phone
1
Chief Scientist/DirectorReveal Email/Phone
2
Sr. VP, Sales & Corporate AccountsReveal Email/Phone
3
Head FacilitiesReveal Email/Phone
4
SVP Global Instrumentation and SoftwareReveal Email/Phone
5
VP Business DevelopmentReveal Email/Phone
6
Head Sales - US MarketReveal Email/Phone
7
VP Corporate CounselReveal Email/Phone
8
VP Finance Lab SolutionsReveal Email/Phone
9
VP Financial Planning & AnalysisReveal Email/Phone
10
VP Operations (Fast Lab)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M520%N/AN/A
#2
$37M1375%N/AN/A
#3
$16.5M68-16%N/AN/A
#4
$42.5M1434%N/AN/A
#5
$48.4M1636%N/AN/A
#6
$25.1M930%N/AN/A
#7
$8.6M4011%N/AN/A
#8
$234.2M6945%N/AN/A
#9
$85.5M28810%N/AN/A
#10
$24.8M927%N/AN/A
Add Company

What Is LumiraDx?

LumiraDx recognizes the need to provide more effective, cost-efficient healthcare for everyone. We make diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences and better value. Founded in 2014 by a group of entrepreneurs with a successful track record of building and scaling diagnostics and health IT businesses, LumiraDx is now expanding the number of representatives and subsidiaries in all continents.

keywords:N/A

N/A

Total Funding

920

Number of Employees

$347.8M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LumiraDx News

2022-04-20 - LumiraDx (NASDAQ:LMDX) Downgraded to Sell at Zacks ...

LumiraDx (NASDAQ:LMDX) Downgraded to Sell at Zacks Investment Research. Posted by admin on Apr 28th, 2022. Share on Twitter Share on Facebook Share on...

2022-04-13 - LumiraDx Limited (NASDAQ:LMDX) Sees Significant ...

LumiraDx Limited (NASDAQ:LMDX) Sees Significant Decrease in Short Interest. Posted by admin on Apr 19th, 2022. Share on Twitter Share on Facebook Share on...

2022-03-22 - LumiraDx Reports Fourth Quarter and Full Year 2021 Results

LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014,...

2019-09-07 - HiSTORIC Validates High-Sensitivity Troponin Test to Rule ...

Mills has acted as a consultant for Abbott Diagnostics, Siemens Healthineers, and LumiraDx; his institution has received grants from Abbott ...

2019-08-31 - Rapid pathway for suspected heart attack enables healthy ...

... outside the submitted work, and honoraria from Abbott Diagnostics, Siemens Healthineers, Roche Diagnostics, Singulex and LumiraDx.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$373.5M920N/AN/A
#2
$315.9M9219%N/A
#3
$224.6M9228%N/A
#4
$348.5M92211%N/A
#5
$284.6M9243%N/A